Page last updated: 2024-09-03

ro 8-0576 and ergoline

ro 8-0576 has been researched along with ergoline in 2 studies

Compound Research Comparison

Studies
(ro 8-0576)
Trials
(ro 8-0576)
Recent Studies (post-2010)
(ro 8-0576)
Studies
(ergoline)
Trials
(ergoline)
Recent Studies (post-2010) (ergoline)
21463674,324381441

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gerlach, J1
Aljanati, R; CaamaƱo, JL; Chouza, C; de Medina, O; Romero, S; Scaramelli, A1

Trials

2 trial(s) available for ro 8-0576 and ergoline

ArticleYear
Effect of CB 154 (2-bromo-alpha-ergocryptine) on paralysis agitans compared with Madopar in a double-blind, cross-over trial.
    Acta neurologica Scandinavica, 1976, Volume: 53, Issue:3

    Topics: Aged; Azides; Benserazide; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Ergolines; Female; Humans; Hydrazines; Hyperkinesis; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Psychoses, Substance-Induced

1976
A combined regimen of subcutaneous lisuride and oral Madopar HBS in Parkinson's disease.
    Journal of neural transmission. Supplementum, 1988, Volume: 27

    Topics: Administration, Oral; Benserazide; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Drug Tolerance; Ergolines; Humans; Hydrazines; Infusion Pumps; Levodopa; Lisuride; Parkinson Disease; Severity of Illness Index

1988